Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Taxol | 0.1 | uM | 4 | 312.50 | 180.13 | 231.00 | 259.50 | 0.8902 | 0.6037 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 205.00 | 259.50 | 0.7900 | 0.2784 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 240.00 | 259.50 | 0.9249 | 0.7243 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 180.00 | 259.50 | 0.6936 | -0.0013 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 153.00 | 259.50 | 0.5896 | -0.2665 | |
| SK-BR-3 | Methotrexate | 0.31623 | uM | 4 | 312.50 | 180.13 | 257.00 | 259.50 | 0.9904 | 0.9636 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 4 | 312.50 | 180.13 | 169.00 | 259.50 | 0.6513 | -0.1140 |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 4 | 312.50 | 180.13 | 273.00 | 259.50 | 1.0520 | 1.2021 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 325.00 | 259.50 | 1.2524 | 2.0662 | |
| SK-BR-3 | Taxol | 0.31623 | uM | 4 | 312.50 | 180.13 | 217.00 | 259.50 | 0.8362 | 0.4242 |
| SK-BR-3 | Palbociclib | 0.01 | uM | 4 | 312.50 | 180.13 | 222.00 | 259.50 | 0.8555 | 0.4871 |
| SK-BR-3 | Taxol | 1 | uM | 4 | 312.50 | 180.13 | 161.00 | 259.50 | 0.6204 | -0.1919 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 4 | 312.50 | 180.13 | 181.00 | 259.50 | 0.6975 | 0.0092 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 381.00 | 259.50 | 1.4682 | 3.1464 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 428.00 | 259.50 | 1.6493 | 4.1711 | |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 4 | 312.50 | 180.13 | 333.00 | 259.50 | 1.2832 | 2.2111 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 4 | 312.50 | 180.13 | 383.00 | 259.50 | 1.4759 | 3.1878 |
| SK-BR-3 | Methotrexate | 1 | uM | 4 | 312.50 | 180.13 | 230.00 | 259.50 | 0.8863 | 0.5905 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 4 | 312.50 | 180.13 | 181.00 | 259.50 | 0.6975 | 0.0092 |
| SK-BR-3 | Taxol | 0.001 | uM | 4 | 312.50 | 180.13 | 254.00 | 259.50 | 0.9788 | 0.9203 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 4 | 312.50 | 180.13 | 165.00 | 259.50 | 0.6358 | -0.1534 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 4 | 312.50 | 180.13 | 189.00 | 259.50 | 0.7283 | 0.0956 |
| SK-BR-3 | Methotrexate | 10 | uM | 4 | 312.50 | 180.13 | 297.00 | 259.50 | 1.1445 | 1.5841 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 4 | 312.50 | 180.13 | 214.00 | 259.50 | 0.8247 | 0.3870 |
| SK-BR-3 | Omipalisib | 3.1623 | uM | 4 | 312.50 | 180.13 | 108.00 | 259.50 | 0.4162 | -0.6213 |